22 Polen Capital Novo Nordisk - ADR Trades
Polen Capital acquired 7.96 Million Novo Nordisk - ADR shares worth $991 Million. That's 2.28% of their equity portfolio (17th largest holding). The first Novo Nordisk - ADR trade was made in Q2 2013. Since then Polen Capital bought shares eighteen more times and sold shares on three occasions. The investor's estimated purchase price is $1.31 Billion, resulting in a loss of 24%.
News about Novo Nordisk - ADR and Polen Capital
BMO Capital starts Novo Nordisk at Outperform
https://www.investing.com/news/stock-market-news/bmo-capital-starts-novo-nordisk-at-outperform-432SI-3376910
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
WHY: NEW YORK, NY - ( NewMediaWire ) - March 03, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities clai...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
WHY: NEW YORK, NY - ( NewMediaWire ) - March 01, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities clai...
Reasons to Hold Novo Nordisk A/S (NVO) for the Long-Term
Rowan Street Capital, an investment management company, released its first half 2023 investor letter. A copy of the same can be downloaded here. The fund gai...